Pediatric Clinical Trials
For more information about a clinical trial,
clinical trial eligibility, or informed consent,
contact our research nurses by phone or email:
Please Note: The eligibility criteria noted below are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any treatment to be undertaken must ultimately be determined on an individual basis by the patient and those involved in the patient's treatment. |
Pediatric Clinical Trials
| Study Title | ||||
|---|---|---|---|---|
| Body Location | Study # | Primary Investigator | More Info | |
A Phase II Study of Conformal Radiotherapy In Patients With Low-Grade Gliomas | ||||
| Brain and Nervous System | ACNS0221 | Chaffee | More Info | |
A Children's Oncology Group Protocol for Collecting and Banking Brain Tumor Research Specimens | ||||
| Brain and Nervous System | ACNS02B3 | Chaffee | More Info | |
A Study Evaluating Limited Target Volume Boost Irradiation and Reduced Dose Craniospinal Radiotherapy (18.00 Gy) and Chemotherapy in Children with Newly Diagnosed Standard Risk Medulloblastoma: A Phase III Double Randomized Trial | ||||
| Brain and Nervous System | ACNS0331 | Chaffee | More Info | |
A Phase III Randomized Study of Chimeric Anti-GD2 in High Risk Neuroblastoma following Myeloablative Therapy and Autologous Stem Cell Transplant (Companion Study to A3973) | ||||
| Brain and Nervous System | ANBL0032 | Chaffee | More Info | |
Neuroblastoma Biology Studies | ||||
| Brain and Nervous System | ANBL00B1 | Chaffee | More Info | |
Perinatal Neuroblastoma: Expectant Observation | ||||
| Brain and Nervous System | ANBL00P2 | Chaffee | More Info | |
Response and Biology-Based Therapy for Intermediate-risk Neuroblastoma | ||||
| Brain and Nervous System | ANBL0531 | Chaffee | More Info | |
A Phase III Study of Reduced Therapy in Treatment of Children with Low and Intermediate Risk Germ Cell Tumors | ||||
| Ill-Defined Sites | AGCT0132 | Chaffee | More Info | |
Renal Tumors: Treatment of High Risk Renal Tumors | ||||
| Kidney | AREN0321 | Chaffee | More Info | |
Renal Tumors Classification, Biology and Banking Study | ||||
| Kidney | AREN03B2 | Chaffee | More Info | |
Treatment for Very Low, Low and Standard Risk Favorable Histology Wilms Tumor | ||||
| Kidney | AREN0532 | Chaffee | More Info | |
High Risk B-Precursor Acute Lymphoblastic Leukemia | ||||
| Lymphoid Leukemia | AALL0232 | Chaffee | More Info | |
Treatment of Late Isolated Extramedullary Relapse from Acute Lymphoblastic Leukemia (ALL) (Initial CR1 Greater than or Equal to 18 Months) | ||||
| Lymphoid Leukemia | AALL02P2 | Chaffee | More Info | |
Standard Risk B-precursor Acute Lymphoblastic Leukemia | ||||
| Lymphoid Leukemia | AALL0331 | Chaffee | More Info | |
Classification of Acute Lymphoblastic Leukemia | ||||
| Lymphoid Leukemia | AALL03B1 | Chaffee | More Info | |
Understanding the Ethnic and Racial Differences in Survival in Children with Acute Lymphoblastic Leukemia (ALL) | ||||
| Lymphoid Leukemia | AALL03N1 | Chaffee | More Info | |
Intensive Treatment for Intermediate-Risk Relapse of Childhood B-Precursor Acute Lymphoblastic Leukemia (ALL): A Randomized Trial of Vincristine Strategies | ||||
| Lymphoid Leukemia | AALL0433 | Chaffee | More Info | |
Intensified Methotrexate, Nelarabine (Compound 506U78; IND #52611) and Augmented BFM Therapy for Children and Young Adults with Newly Diagnosed T-cell Acute Lymphoblastic Leukemia (ALL) | ||||
| Lymphoid Leukemia | AALL0434 | Chaffee | More Info | |
A Phase III Randomized Trial of Gemtuzumab Ozogamicin (Mylotarg®) Combined with Conventional Chemotherapy for De Novo Acute Myeloid Leukemia (AML) in Children, Adolescents, and Young Adults | ||||
| Myeloid and Monocytic Leukemia | AAML0531 | Chaffee | More Info | |
Vincristine, Dactinomycin, and Lower Doses of Cyclophosphamide With or Without Radiation Therapy for Patients with Newly Diagnosed Low-Risk Embryonal/Botryoid/Spindle Cell Rhabdomyosarcoma - A Phase III Group-Wide Study | ||||
| Soft Tissue | ARST0331 | Chaffee | More Info | |
Risk-Based Treatment for Pediatric Non-Rhabdomyosarcoma Soft Tissue Sarcomas (NRSTS) | ||||
| Soft Tissue | ARST0332 | Chaffee | More Info | |
Randomized Study of Vincristine, Dactinomycin and Cyclophosphamide (VAC) versus VAC Alternating with Vincristine and Irinotecan (VI) for Patients with Intermediate-RiskRhabdomyosarcoma (RMS) | ||||
| Soft Tissue | ARST0531 | Chaffee | More Info | |
A COG Soft Tissue Sarcoma Diagnosis, Biology and Banking Protocol | ||||
| Soft Tissue | PD9902 | Chaffee | More Info | |
